Search
laropiprant/nicotinic acid {Niaspan, laropiprant} (Cordaptive)
Indications:
- hypercholesterolemia
Mechanism of action:
- an investigational extended-release niacin product containing laropiprant, a new flushing blocker
General
pharmacologic combination
References
- Prescriber's Letter 15(4): 2008
New Formulation Simcor and the Investigational Drug Cordaptive
Detail-Document#: 240411
(subscription needed) http://www.prescribersletter.com
Components
laropiprant
nicotinic acid (niacin, vitamin B3, Niaspan)